Fortis Capital Advisors’s Clorox CLX Stock Holding History

Fortis Capital Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-189	Closed	-$29.9K	–	201
2023 Q1	$29.9K	Sell	189 -111	-37%	-$16.6K	0.02%	358
2022 Q4	$42.1K	Buy	+300	New	+$42.6K	0.03%	312

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fortis Capital Advisors's CLX Position: Q2 2023 in Review

Fortis Capital Advisors sold out of Clorox (CLX) in Q2 2023, closing a stake of 189 shares — an estimated $29.9K sold.

Fortis Capital Advisors first reported a position in CLX in Q4 2022 and held it in 2 quarters. The position peaked at $42.1K in Q4 2022. 1,143 funds tracked by Wall St. Rank hold CLX as of Q2 2023.

Fortis Capital Advisors reported no remaining Clorox position as of Q2 2023 after selling out during the quarter.
Fortis Capital Advisors sold 189 Clorox shares in Q2 2023, an estimated $29.9K.
Fortis Capital Advisors first reported a position in Clorox in Q4 2022 and held it in 2 quarters.
Fortis Capital Advisors's Clorox position peaked at $42.1K in Q4 2022.
1,143 funds tracked by Wall St. Rank held Clorox as of Q2 2023.

Based on Fortis Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.